Allscripts Healthcare Stock Analysis, Valuation (NASDAQ:MDRX)

Add to My Stocks
$13.17 $0.18 (1.35%) MDRX stock closing price Mar 16, 2018 (Closing)
Watch Robo Advisor Video of MDRX Stock Analysis
Allscripts Healthcare
Updated on : Mar 16, 2018
previous close
MDRX 13.4 (0%)
S&P 500 2747.3 (0%)
Closing Price On: Mar 15, 2018
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical-Information Systems
Sector :
5 Quarter Revenue
Revenue Growth
Compared to the industry
Operating Profit
Operating Margin:
Sector Average:
5 Quarter Net Profit
Net Margins
LTM Margin
Debt/Equity Ratio
Debt/Equity Ratio:
Compared to the industry
Cash Flow
Operating cash flow:
Net Income:
Recent Growth
Operating Margins
PS Valuation
FCF Margin
Net Margins
High Debt Burden
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
Industry PS :
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
Return on Equity:
Free Cash Flow Margin:
Double Tap To Exit Full Screen

Allscripts Healthcare Stock Analysis

85 5 2

Investors can watch the Amigobulls Allscripts Healthcare stock analysis video here. Our analyst opinion covering the buy and sell arguments for MDRX stock is shown in the video.

Note: Amigobulls stock rating is our opinion based on the historical performance of the company's fundamentals. It is not indicative of the future performance of the stock.

Allscripts Healthcare Solutions Inc Stock Rating 2.7/5

Amigobulls MDRX stock analysis relies on business fundamentals such as Allscripts Healthcare revenue growth, profits and return on equity measures from the latest quarter 2017 Q3 earnings. Allscripts Healthcare valuation forms a crucial part of our stock analysis. Allscripts Healthcare stock rating is our opinion about the business fundamentals of the company.

Should you buy MDRX stock?

  • Allscripts Healthcare sales grew by 21.6% year on year in 2017 Q4.
  • Allscripts Healthcare had a healthy average operating margin of 2.3% over the last 4 quarters.
  • When compared with the Medical-Information Systems industry average PS ratio of 4.2, the price-to-sales ratio of 1.4 for MDRX stock is attractive.
  • Allscripts Healthcare generates a high return on invested capital of 1.1%.
  • The company has a good Free Cash Flow (FCF) margin of 13.2%.

Should you sell MDRX stock?

  • Allscripts Healthcare posted an average Net loss of -10.9% in the last twelve months.
  • Allscripts Healthcare is debt laden and has a high debt/equity ratio of  1.36.
  • Allscripts Healthcare has a negative ROE (Return On Equity) of -16.6%, indicating the company is not profitable.

Allscripts Healthcare Related Company Stock Videos

Comments on this video and Allscripts Healthcare stock

Investors can make use of the Amigobulls Allscripts Healthcare stock analysis to ascertain how MDRX stock fares in fundamental analysis investment criteria. Fundamentals of a company give detailed information which helps in making invesment decisions.

While doing a study of the company financials, Allscripts Healthcare revenue growth and profit or net income are two main metrics which help in identifying whether MDRX stock is overvalued or undervalued. Investors could make use of MDRX technical analysis to check whether the fundamental story is reflected in the market sentiment.